Mass spectrometry support for cancer prevention and understanding how cancer begins
Mass Spectrometric Analytical Collaborations with Members of the Carcinogenesis and Chemoprevention Program of the University of Minnesota Masonic Cancer Center
This project uses advanced mass spectrometry to help cancer scientists find chemical changes that might lead to better prevention and early-detection for people at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11145631 on NIH RePORTER |
What this research studies
This project runs a mass spectrometry laboratory that analyzes biological samples for cancer researchers in the Carcinogenesis and Chemoprevention Program. The lab measures chemicals, potential biomarkers, and molecular changes in tissues, blood, and other samples to help explain how cancer starts and how it might be prevented. Staff work closely with investigators, providing consultation, training, and direct analytical services for many NCI-funded projects. Their analyses help turn laboratory findings into practical leads for prevention and early-detection strategies.
Who could benefit from this research
Good fit: Ideal candidates are people with cancer or at increased cancer risk who are enrolled in clinical or biospecimen studies at the University of Minnesota or with collaborating investigators.
Not a fit: People who are not enrolled in related cancer studies or cannot provide biological samples would not directly benefit from this grant's activities.
Why it matters
Potential benefit: If successful, this work could help researchers identify chemical markers and targets that lead to improved cancer prevention and earlier detection.
How similar studies have performed: Mass spectrometry is an established tool for finding cancer biomarkers and studying carcinogenesis, so this work builds on well-used methods rather than being entirely novel.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Villalta, Peter William — University of Minnesota
- Study coordinator: Villalta, Peter William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.